We are live on ! Find out more
PI

Putnam Investments Portfolio holdings

AUM $75.7B
1-Year Est. Return 34.45%
This Fund
S&P 500
This Quarter Est. Return
-2.34%
1 Year Est. Return
+34.45%
3 Year Est. Return
+61.95%
5 Year Est. Return
+203.43%
10 Year Est. Return
+442.91%
AUM
$52.6B
AUM Growth
-$3.21B
Cap. Flow
-$1.26B
Cap. Flow %
-2.4%
Top 10 Hldgs %
24.55%
Holding
1,245
New
126
Increased
333
Reduced
642
Closed
106

Top Buys

Rank Stock Value
1
IR icon
Ingersoll Rand
IR
+$286M
2
HUM icon
Humana
HUM
+$224M
3
LLY icon
Eli Lilly
LLY
+$143M
4
ABT icon
Abbott
ABT
+$110M
5
BALL icon
Ball Corp
BALL
+$104M

Sector Composition

Rank Sector Weight
1 Technology 20.38%
2 Healthcare 18.47%
3 Financials 12.77%
4 Consumer Discretionary 10.16%
5 Industrials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CASH icon
751
Pathward Financial
CASH
$1.81B
$1.09M ﹤0.01%
33,009
-601
-2% -$21.6K
EAF icon
752
GrafTech
EAF
$205M
$1.09M ﹤0.01%
25,205
+20,286
+412% +$1.29M
AGEN
753
Agenus
AGEN
$291M
$1.07M ﹤0.01%
26,673
-486
-2% -$24.8K
AMR icon
754
Alpha Metallurgical Resources
AMR
$1.95B
$1.06M ﹤0.01%
+7,757
New +$1.08M
TBPH icon
755
Theravance Biopharma
TBPH
$876M
$1.04M ﹤0.01%
102,156
-1,852
-2% -$17.4K
NWN icon
756
Northwest Natural Holdings
NWN
$2.09B
$1.03M ﹤0.01%
23,705
-432
-2% -$21.9K
ALE
757
DELISTED
Allete
ALE
$1.02M ﹤0.01%
20,325
-368
-2% -$21.9K
RAMP icon
758
LiveRamp
RAMP
$2.3B
$1.02M ﹤0.01%
56,004
-1,023
-2% -$23.6K
ALEC icon
759
Alector
ALEC
$189M
$1.01M ﹤0.01%
106,986
-1,937
-2% -$20.9K
FMTX
760
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$1M ﹤0.01%
+50,399
New +$665K
ARCB icon
761
ArcBest
ARCB
$3.07B
$993K ﹤0.01%
13,651
-249
-2% -$20K
NXGN
762
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$993K ﹤0.01%
56,112
-1,009
-2% -$17.5K
IMXI icon
763
International Money Express
IMXI
$356M
$992K ﹤0.01%
43,514
-4,237
-9% -$99.6K
GLNG icon
764
Golar LNG
GLNG
$5.16B
$991K ﹤0.01%
39,768
-722
-2% -$18K
ASIX icon
765
AdvanSix
ASIX
$438M
$975K ﹤0.01%
30,362
-556
-2% -$20K
CDXS icon
766
Codexis
CDXS
$161M
$975K ﹤0.01%
160,756
+81,205
+102% +$653K
SNEX icon
767
StoneX
SNEX
$7.81B
$966K ﹤0.01%
+58,948
New +$1.01M
PRDO icon
768
Perdoceo Education
PRDO
$1.97B
$949K ﹤0.01%
92,104
-1,687
-2% -$20.1K
HOUS
769
DELISTED
Anywhere Real Estate
HOUS
$939K ﹤0.01%
115,799
-2,105
-2% -$21.6K
ALEX
770
DELISTED
Alexander & Baldwin
ALEX
$937K ﹤0.01%
56,485
-1,035
-2% -$19K
RYZ
771
Ryerson Holding Corp
RYZ
$1.45B
$934K ﹤0.01%
36,269
-136,189
-79% -$3.62M
SUMO
772
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
$924K ﹤0.01%
+123,145
New +$983K
SPXC icon
773
SPX Corp
SPXC
$10.6B
$915K ﹤0.01%
16,570
-2,386
-13% -$137K
BGC icon
774
BGC Group
BGC
$4.86B
$911K ﹤0.01%
290,175
-5,285
-2% -$20.5K
BANR icon
775
Banner Corp
BANR
$2.43B
$910K ﹤0.01%
15,397
-278
-2% -$16.8K

Similar funds

Putnam Investments's Q3 2022 Portfolio in Review

As of Q3 2022, Putnam Investments held 1,245 positions worth $52.6B, down 5.8% from $55.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Putnam Investments's Q3 2022 filing shows 126 new, 333 increased, 642 reduced and 106 closed positions. Its largest new stake was iShares MSCI India ETF: 303,491 shares worth $12.4M. The largest sale was Johnson & Johnson, an estimated $518M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Putnam Investments's largest Q3 2022 buy was iShares MSCI India ETF: 303,491 shares worth $12.4M.
  • Putnam Investments added most to Ingersoll Rand in Q3 2022, an estimated $286M increase.
  • Putnam Investments's biggest Q3 2022 reduction was Johnson & Johnson, cutting an estimated $518M.
  • Putnam Investments fully exited Pershing Square Tontine Holdings, Ltd. in Q3 2022, selling an estimated $34.2M.
  • Putnam Investments's ten largest holdings make up 25% of its $52.6B portfolio in Q3 2022.
  • Putnam Investments opened 126 new positions and closed 106 in Q3 2022.
  • Putnam Investments's portfolio value fell 5.8% quarter-over-quarter to $52.6B.

Based on Putnam Investments's 13F filing for Q3 2022, filed 14 Nov 2022.